We demonstrated that genetic reduction in PCSK9 function significantly reduces the risk of AAA, a finding that was previously described in PheWAS of the rs11591147 variant and Mendelian randomization experiments in MVP [8]. The gene discussed is PCSK9; the disease is triple-A syndrome.